OOIR: Observatory of International Research

Papers

(The median citation count of Cancer Communications is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Issue Information	750
Issue Information	450
	403
	263
Single‐cell transcriptomics and epigenomics point to CD58‐CD2 interaction in controlling primary melanoma growth and immunity	248
Issue Information	237
Nine‐fold variation of risk of advanced colorectal neoplasms according to smoking and polygenic risk score: Results from a cross‐sectional study in a large screening colonoscopy cohort	214
	189
Loss of CDKN1B induces an age‐related clonal hematopoietic disorder via Notch2 activity dysregulation	173
Fascin lysine 471 acetylation cooperates with serine 39 phosphorylation to inhibit actin‐bundling activity and tumor metastasis in esophageal squamous cell carcinoma	171
Defining and tracing subtypes of patient‐derived xenograft models in pancreatic ductal adenocarcinoma	155
Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study	153
Long‐term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study	144
Kindlin‐1 drives early steps of breast cancer metastasis	135
Current status and perspectives of esophageal cancer: a comprehensive review	135
Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy	134
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update	134
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives	130
Issue Information	108
Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with h	106
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinica	103
P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer	103
Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer	99
p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases	98
Impact of pre‐existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study	97

Nasopharyngeal carcinoma treatment paradigm after HK0501 – a potential way forward	96
Research trends of cancer metabolism: analysis from a Chinese perspective	92
A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer	91
Single‐cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesions	89
Efficacy and safety of first‐line sintilimab plus anlotinib versus chemotherapy for metastatic non‐small cell lung cancer: a phase II, open‐label, randomized controlled trial	87
	85
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program	76
Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity	74
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer	74
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates	74
N⁶‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis	70
Comparative single‐cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses	67
Development and validation of an artificial intelligence model for predicting post‐transplant hepatocellular cancer recurrence	61
Multifunctional inorganic nanomaterials for cancer photoimmunotherapy	59
Issue Information	58
	57
Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma	56
Association between antipsychotic agents and risk of lung cancer: a nested case‐control study	50
	47
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2	47
Cover Image, Volume 42, Issue 1	47
FOXO1 or not FOXO1: that is the question	44
Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma	44
Impact of small molecule‐mediated inhibition of ammonia detoxification on lung malignancies and liver metabolism	43
Comprehensive DSRCT multi‐omics analyses unveil CACNA2D2 as a diagnostic hallmark and super‐enhancer‐driven EWSR1::WT1 signature gene	42
Incidence of and survival with bone and soft tissue sarcoma: A nation‐wide study over four decades	42
Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer	41
A strong internal promoter drives massive expression of YEATS‐domain devoid MLLT3 transcripts in HSC and most lethal AML	41
Antitumoral effects of cannabis in Notch1‐mutated T‐cell acute lymphoblastic leukemia	41
Ubiquitination in cancer: mechanisms and therapeutic opportunities	40
Cover Image, Volume 45, Issue 6	40
Association of previously irradiated stable brain metastases with outcomes of atezolizumab‐treated non‐small cell lung cancer: A pooled analysis of individual patient data from three randomized trials	38
First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial	38
Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2‐mediated increase of SOAT2 RNA methylation	38
Correction to: **ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin‐3 and NRXN3**	37
Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis	37
Issue Information	35
Transcriptomic analyses of localized prostate cancers of East Asian and North American men reveal race‐specific luminal‐basal and microenvironmental differences	35
Low household income and income volatility increase risk of lung cancer: A nationwide retrospective cohort study	34
Transcriptional suppression of CD8⁺ T cell exhaustion for improving T cell immunotherapy	33
Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi‐phased study of prostate cancer	33
An HGF‐dependent positive feedback loop between bladder cancer cells and fibroblasts mediates lymphangiogenesis and lymphatic metastasis	32
m⁶A‐modified EHD1 controls PD‐L1 endosomal trafficking to modulate immune evasion and immunotherapy responses in lung adenocarcinoma	30
Enhanced selection of people for lung cancer screening using AHRR (cg05575921) or F2RL3 (cg03636183) methylation as biological markers of smoking exposure	29
Development of antibody‐drug conjugates in cancer: Overview and prospects	28
Breast cancer: an up‐to‐date review and future perspectives	28
Long‐term outcomes of intraoperative radiotherapy for early‐stage breast cancer in China: a multicenter real‐world study	28
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer	27
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract	27
Genomic information of children with malignant brain tumors for the prediction of length of hospitalization	26

JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps	26
Inhibition of mTOR attenuates the initiation and progression of BRCA1‐associated mammary tumors	26
Long‐term antibiotic use and risk of hepatocellular carcinoma later in life: a nationwide cohort study of 9.8 million participants	26
4‐1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4‐1BB agonists	26
Spatial metabolomics for evaluating response to neoadjuvant therapy in non‐small cell lung cancer patients	26
Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas	25
DNA methylation signature predicts cancer response to demethylation agents from profiling diverse cancer cell lines	25
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine	25
N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA	25
	24
Single‐cell and bulk transcriptomics identifies a tumor‐specific CD36⁺ cancer‐associated fibroblast subpopulation in colorectal cancer	23
Knowing nodal Rouviére: the power of human intelligence in toxicity reduction	23
Issue Information	23
Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium	23
Issue Information	23
The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression	22
Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD‐3 study	22
Galectin 3‐binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor‐β1 (TGF‐β1) availability and inhibits hepatocarcinogenesis	22
Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms	21
Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence	21
Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins	20
Issue Information	20
Cover Image, Volume 44, Issue 4	20
Breaking barriers: Smart vaccine platforms for cancer immunomodulation	20
Cover Image, Volume 43, Issue 6	20
Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy	20
Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti‐PD‐1 therapy	20
Tumor microenvironment signaling and therapeutics in cancer progression	20
A moonlighting function of choline kinase alpha 2 in the initiation of lipid droplet lipolysis in cancer cells	20
Advanced precision modeling reveals divergent responses of hepatocellular carcinoma to combinatorial immunotherapy	19
Leptin‐mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer	19
Targeting ferroptosis resistance resensitizes metastatic HR⁺HER2⁻ breast cancer cells to palbociclib‐hormone therapy	19
A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment	19
The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non‐small cell lung cancer patients with epidermal growth factor receptor mutation	18
Enhancing sensitivity of triple‐negative breast cancer to DNA‐damaging therapy through chemical inhibition of the m6A methyltransferase METTL3	18
	18
	17
Single‐cell‐eQTL mapping in circulating immune cells reveals genetic regulation of response‐associated networks in lung cancer immunotherapy	17
The regulatory roles and clinical significance of glycolysis in tumor	17
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors	17
The SARS‐CoV‐2 spike protein induces lung cancer migration and invasion in a TLR2‐dependent manner	16
RGS12 inhibits the progression and metastasis of multiple myeloma by driving M1 macrophage polarization and activation in the bone marrow microenvironment	16
Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients	16
Targeting N4‐acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2‐mediated HMGB2 mRNA translation	16
Issue Information	16
Single‐cell atlas reveals a distinct immune profile fostered by T cell‐B cell crosstalk in triple negative breast cancer	16
Evolution of tumor microenvironment in colorectal liver metastases under treatment stress	16
Perivascular localized cells commit erythropoiesis in PDGF‐B‐expressing solid tumors	16
Ferroptosis in cancer and cancer immunotherapy	16
Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS)	16
Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China	16
Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinica	16
Proteomic identification of new diagnostic biomarkers of early‐stage cutaneous mycosis fungoides	16
Lysosomal TMEM9‐LAMTOR4‐controlled mTOR signaling integrity is required for mammary tumorigenesis	16
Issue Information	15
Tumor‐derived insulin‐like growth factor‐binding protein‐1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors	15
Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study	15
Issue Information	15
Diagnostic value of genetic mutation analysis and mutation profiling of cell‐free DNA in intraocular fluid for vitreoretinal lymphoma	14
Discovery of a novel viroid‐like circular RNA in colorectal cancer	14
Targeted STAT1 therapy for LZTR1‐driven peripheral nerve sheath tumor	14
	14
Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open‐label, multicenter, phase Ib trial	14
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models	14
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma	14
Unraveling the routes to distant metastases in colorectal cancer: Tumor deposits and lymph node metastases as the gateway	14
NHE7 upregulation potentiates the uptake of small extracellular vesicles by enhancing maturation of macropinosomes in hepatocellular carcinoma	13
Transient and DNA‐free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis	13
Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis	13
Smoking, smoking cessation, and survival after cancer diagnosis in 128,423 patients across cancer types	13
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma	12
Exciting progress in targeted therapy innovation for unresectable stage III EGFR‐mutated NSCLC: the phase III LAURA study	12
Issue Information	12
Methionine restriction sensitizes cancer cells to immunotherapy	12
A phase II study on Mefatinib as first‐line treatment of patients with advanced non‐small‐cell lung cancer harboring uncommon EGFR mutations	12
Cover Image, Volume 43, Issue 12	12
Lung cancer risk score for ever and never smokers in China	12
Engineering heavy chain antibody‐drug conjugates against solid tumors for a one‐shot kill	12
Issue Information	12
Cover Image, Volume 42, Issue 6	11

Combating cancer immunotherapy resistance: a nano‐medicine perspective	11
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment	11
Combining methylated SEPTIN9 and RNF180 plasma markers for diagnosis and early detection of gastric cancer	11
Plasma small‐extracellular vesicles enriched in miR‐122‐5p promote disease aggressiveness in pediatric anaplastic large‐cell lymphoma	10
	10
	10
Clinical characteristics and outcomes of Chinese patients with KRAS‐mutant non‐small cell lung cancer after chemotherapy	10
Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets	10
Vascular smooth muscle cell plasticity in the tumor microenvironment	10
	10
Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity	10
Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF‐α signaling	10
Cover Image, Volume 43, Issue 9	10
Dynamic epi‐transcriptomic landscape mapping with disease progression in estrogen receptor‐positive breast cancer	10
Stereotactic body radiotherapy plus cadonilimab (PD‐1/CTLA‐4 bispecific antibody) as third‐line or beyond therapy for refractory solid tumors: A phase 1b study	9
Issue Information	9
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023	9
Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis	9
Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer	9
Nicotinamide N‐methyltransferase negatively regulates metastasis‐promoting property of cancer‐associated fibroblasts in lung adenocarcinoma	9
Training the synergy between Bacillus Calmette‐Guérin and immune checkpoint‐blocking antibodies in bladder cancer	9
MFSD2A potentiates gastric cancer response to anti‐PD‐1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response	9
Loss of ID3 in pancreatic cancer cells increases DNA damage without impairing MDC1 recruitment to the nuclear foci	8
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy	8
Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple‐negative breast cancer to immune checkpoint inhibitors	8
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy	8
KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer	8
Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial	8
Transcriptome‐wide association analysis identified candidate susceptibility genes for nasopharyngeal carcinoma	8
Targeting MAN1B1 potently enhances bladder cancer antitumor immunity via deglycosylation of CD47	8
Cover Image, Volume 42, Issue 8	7
Cover Image, Volume 42, Issue 6	7
Cover Image, Volume 43, Issue 11	7
Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study	7
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross‐over pharmacokinetic drug‐drug interaction study	7
Intratumoral CD103⁺CD8⁺ T cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma	7
Tumor derived cell‐free nucleic acid upregulates programmed death‐ligand 1 expression in neutrophil via intracellular Toll‐like receptor signaling	7
Vitamin D₃ for reducing mortality from cancer and other outcomes before, during and beyond the COVID‐19 pandemic: A plea for harvesting low‐hanging fruit	7
Survival trends of patients with non‐metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates	7
NAT10 regulates tumor progression and immune microenvironment in pancreatic ductal adenocarcinoma via the N4‐acetylated LAMB3‐mediated FAK/ERK pathway	7
Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib	7
Cover Image, Volume 41, Issue 12	7
	7
Issue Information	7
Detection of pancreatic cancer by indocyanine green‐assisted fluorescence imaging in the first and second near‐infrared windows	7
Simvastatin overcomes the pPCK1‐pLDHA‐SPRINGlac axis‐mediated ferroptosis and chemo‐immunotherapy resistance in AKT‐hyperactivated intrahepatic cholangiocarcinoma	7
Unveiling quality of clinical trial in China: from concern to confirmation	7
	6
Parkin deficiency promotes colorectal tumorigenesis and progression through RIPK3‐dependent necroptotic inflammation	6
Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome‐wide association and whole genome sequencing analyses	6
Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a “hit‐and‐run” paradigm	6
A novel intronic circular RNA, circGNG7, inhibits head and neck squamous cell carcinoma progression by blocking the phosphorylation of heat shock protein 27 at Ser78 and Ser82	6
A serum exosomal microRNA‐based artificial intelligence diagnostic model for highly accurate detection of hepatocellular carcinoma	6
Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells	6
	6
The interplay between natural killer cells and pancreatic stellate cells in pancreatic ductal adenocarcinoma	6
Serologic status and safety of inactivated Covid‐19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection	6
Issue Information	6
Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1	6
Issue Information	6
Phosphatidylserine released from apoptotic cells in tumor induces M2‐like macrophage polarization through the PSR‐STAT3‐JMJD3 axis	6
Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor	6
Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors	5
Single‐cell transcriptomic analysis uncovers intratumoral heterogeneity and drug‐tolerant persister in ALK‐rearranged lung adenocarcinoma	5
Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression	5
Non‐small cell lung cancer in China	5
SALIRI‐based (raltitrexed plus irinotecan) therapy as a second‐line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non‐interventional, registry study	5
Issue Information	5
miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies	5
Issue Information	5
Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21‐mediated ubiquitination/degradation of STAT1 in a GTP binding‐dependent modality	5
	5
Exposure of benzo[a]pyrene induces HCC exosome‐circular RNA to activate lung fibroblasts and trigger organotropic metastasis	5
NAT10‐mediated ac⁴C‐modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear‐cell renal cell carcinoma by attenuating YWHAE‐driven cytoplasmic retention of YAP1	5
Front Cover: Nuclear Aurora kinase A triggers programmed death‐ligand 1‐mediated immune suppression by activating MYC transcription in triple‐negative breast cancer	5
Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway	5
Dysfunction of dendritic cells in tumor microenvironment and immunotherapy	5
Single whole‐genome sequencing analysis of metastatic biopsy is sufficient for investigational treatment opportunities in cancer	5
Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis	5
Issue Information	5
m⁶A‐mediated regulation of PBX1‐GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels	5
ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients	5
Activation mechanisms of clinically distinct B‐Raf V600E and V600K mutants	5
A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability	5
Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2	4
A global assessment of recent trends in gastrointestinal cancer and lifestyle‐associated risk factors	4
Multi‐omic study to unmask genes involved in prostate cancer development in a multi‐case family	4
Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors	4
Unraveling the effects of screening colonoscopy on colorectal cancer early detection and prevention: the NordICC trial revisited	4
Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer	4
Immunosuppressive JAG2⁺ tumor‐associated neutrophils hamper PD‐1 blockade response in ovarian cancer by mediating the differentiation of effector regulatory T cells	4
Older adults living with gastrointestinal cancers in 2021	4
Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor	4
Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors	4
A phase II basket trial of dual anti‐CTLA‐4 and anti‐PD‐1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic	4